NCT05700747 Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma Status COMPLETED Phase NA
NCT05698888 Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors Status TERMINATED Phase PHASE1
NCT05698303 A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE1
NCT05697913 Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation Status ACTIVE_NOT_RECRUITING Phase NA
NCT05693012 Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma Status UNKNOWN Phase N/A
NCT05690984 Elimination of Minimal Residual Disease After Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05686447 Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis Status RECRUITING Phase N/A
NCT05679258 A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects Status COMPLETED Phase PHASE1
NCT05675449 A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05675319 Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy Status TERMINATED Phase PHASE3
NCT05673083 Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05655546 ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals Status TERMINATED Phase NA
NCT05652530 Clinical Study of the Safety and Efficacy of BCMA CAR-NK Status UNKNOWN Phase EARLY_PHASE1
NCT05651932 A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma Status RECRUITING Phase PHASE1
NCT05650632 A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1
NCT05646836 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05646758 A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects Status RECRUITING Phase PHASE1